Advocacy

/ Advocacy / Key Issues / Access to Medications / Asthma Quick-Relief Medicines in Schools

Asthma Quick-Relief Medicines in Schools​

AAFA supports school policies that promote access to life-saving medicines to treat students and staff who experience asthma attacks or severe allergic reactions. Since 2012, most states have passed laws that allow or require schools to keep a supply of epinephrine auto-injectors for use in allergy emergencies. States should also allow schools to keep a supply of emergency asthma medicine, such as albuterol, on hand.

AAFA encourages states to adopt policies that promote access to medicine and protect students and staff. This includes supplying schools with quick-relief medicines, such as albuterol inhalers, to be used in emergencies, appropriately training school personnel, and addressing liability concerns for those who use this medicine in good faith.

Does Your State Stock Asthma Quick-Relief Medicine in Schools?

Albuterol Stocking Map State by State 2021

State Legislation for Stocking Asthma Quick-Relief Medicine in Schools

More information about each state’s laws:

Federal Legislation Encourages Asthma Management

In January 2021, the School Based Allergies and Asthma Management Program Act (HR 2468) became law. This law encourages states to improve asthma care in schools by giving preference for federal grants to states that adopt certain asthma management programs and policies. While this legislation does not require states to allow albuterol stocking in schools, it would encourage schools to put into place:

  • Methods to identify all students who have allergies or asthma
  • Individual student action plans
  • School nurses or trained staff on-site during operating hours to give medicines for both asthma and allergies
  • Education for school staff
  • Efforts to reduce environmental triggers
  • Support for families managing asthma and allergies

Updated December 2024